申请人:Medshine Discovery Inc.
公开号:EP4043455A1
公开(公告)日:2022-08-17
A compound represented by formula (III) or a pharmaceutically acceptable salt thereof, and disclosed is an application thereof in the preparation of a medication for treating diseases related to a CRBN receptor.
公式(III)所代表的化合物或其药学上可接受的盐,并且公开了其在制备治疗与CRBN受体相关的疾病的药物中的应用。